课题基金 / 基金详情

POG 9426 TREATMENT OF HODGKINS DISEASE WITH DBVE AND IRRADIATION

POG 9426 TREATMENT OF HODGKINS DISEASE WITH DBVE AND IRRADIATION
POG 9426 用 DBVE 和辐射治疗霍奇金病
批准号：
6279252
负责人：
FAITH H KUNG
金额：
$1.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279252
关键词：
Hodgkin's disease bleomycin cardiopulmonary disease clinical research combination therapy cytotoxicity doxorubicin drug adverse effect human subject human therapy evaluation myocardium disorder neoplasm /cancer chemotherapy neoplasm /cancer radiation therapy vincristine

项目摘要

项目成果

FAITH H KUNG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
POG 9426 to examine activity of variable courses of doxorubicin, bleomycin, vincristine, andetoposide (DBVE) and low dose involved field irradiation in treatment of early stage hodgkin's disease. Evaluate acute and chronic toxicities, examine if addition of zinecard can reduce cardiopulmonary toxicity and determine if frequency and magnitude of myocardial injury during therapy is reduced by addition of zinecard.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POG 9575 TOPOTECAN FOR REFRACTORY LEUKEMIA
POG 9572 BYROSTATIN IN CHILDREN WITH SOLID TUMORS
POG 9571 IRINOTECAN IN CHILDREN WITH SOLID TUMORS
POG9470--CI 980 IN CHILDREN WITH SOLID TUMORS
海外基金